Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 155,400,262	$ 150,145,844
Accounts receivable	21,166,129	21,130,951
Inventory	49,563,880	64,218,337
Prepaid expenses and other current assets	4,914,613	3,496,028
Total current assets	231,044,884	238,991,160
Property, plant and equipment, net	1,298,423	1,331,708
Deferred tax asset, net	10,854,702	11,048,118
Goodwill	898,334	898,334
Other assets	240,683	2,083,535
Total assets	244,337,026	254,352,855
Liabilities, Current [Abstract]
Accounts payable	1,340,337	1,456,316
Accrued Liabilities, Current	5,640,110	10,181,810
Deferred IV TPOXX® revenue	10,330,800	20,788,720
Income tax payable	8,020,366	21,690,899
Total current liabilities	25,331,613	54,117,745
Other Liabilities	3,200,650	3,376,203
Total liabilities	28,532,263	57,493,948
Commitments and contingencies (Note 12)
Stockholders' equity
Common stock ($.0001 par value, 600,000,000 shares authorized, 71,404,669 and 71,091,616 issued and outstanding at December 31, 2024 and December 31, 2023, respectively)	7,140	7,109
Additional paid-in capital	238,635,635	235,795,420
Accumulated deficit	(22,838,012)	(38,943,622)
Total stockholders' equity	215,804,763	196,858,907
Total liabilities and stockholders' equity	$ 244,337,026	$ 254,352,855